Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience.
- Published in:
- 2023
- Publication type:
- Correction Notice
Works matching IS 13300962 AND DT 2023 AND VI 33 AND IP 3
Results: 14
1
2
Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.031001
- By:
- Publication type:
- Article
3
Undetectable high-performance liquid chromatography haemoglobin A1c on variant haemoglobin E phenotype: a case report.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030801
- By:
- Publication type:
- Article
4
Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030705
- By:
- Publication type:
- Article
5
Establishment of age- and -gender specific reference intervals for amino acids and acylcarnitines by tandem mass spectrometry in Turkish paediatric population.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030704
- By:
- Publication type:
- Article
6
Negligible effect of vitamin D supplementation on exacerbation in patients with chronic obstructive pulmonary disease: meta-analysis.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030703
- By:
- Publication type:
- Article
7
Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030702
- By:
- Publication type:
- Article
8
Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1a concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030701
- By:
- Publication type:
- Article
9
What did CRISPR-Cas9 accomplish in its first 10 years?
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030601
- By:
- Publication type:
- Article
10
The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030505
- By:
- Publication type:
- Article
11
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030504
- By:
- Publication type:
- Article
12
Carbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030503
- By:
- Publication type:
- Article
13
Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes: a narrative review.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030502
- By:
- Publication type:
- Article
14
Diagnostic challenges of diabetic kidney disease.
- Published in:
- Biochemia Medica, 2023, v. 33, n. 3, p. 1, doi. 10.11613/BM.2023.030501
- By:
- Publication type:
- Article